VXRT News and Press, Vaxart Inc. From 05/01/21

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha, Apple Po...

Listen on the go! A daily podcast of Wall Street Breakfast's Alpha Talks will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify. Stocks fell broadly Friday, as investors took profits following a flurry of earnings reports, including a blowout quarter from Amazon, and an...

Vaxart stock has gained 54% over the past month as the company continues to press its case for an oral COVID vaccine. Its phase 1 trial results were considered disappointing but Vaxart has issued a robust response. The company is still under investigation for possibly making misle...

Vaxart (VXRT), which is developing an oral COVID-19 vaccine, is up more than 9% to $9.21 in afternoon trading as chatter on the Wall Street Bets Reddit channel heats up and the company announced its founder will present at a major vaccines conference.Sean Tucker, who is also chief s...

SOUTH SAN FRANCISCO, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT), a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced that its founder and chief scientific officer, S...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning and welcome to the stock market today! For investors, an upcoming policy decision from the Federal Reserve is a key factor this morning. Earnings from tech giants like Microsoft (NASDAQ: MSFT ) are also m...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips One of the largest roadblocks in the progress toward Covid-19 reopening is the seemingly endless cropping up of new strains. Now, with a coming webinar hosted by Vaxart (NASDAQ: VXRT ), we might be looking at treatmen...

Vaxart ([[VXRT]] +46.5%) shares are on the rise today, and if the rally holds the stock appears to be on course to post its highest one-day gain since early February.So far 150.7M Vaxart shares have changed hands more than 11 times the 65-day average volume at ~13.4M.Despite the resignation o...

Gainers: Tian Ruixiang (TIRX) +54%.Vaxart (VXRT) +51%.RiceBran Technologies (RIBT) +47%.Aldeyra Therapeutics (ALDX) +31%.NetSol Technologies (NTWK) +30%.First Choice Bancorp (FCBP) +28%.TrueBlue (TBI) +26%.Brooklyn ImmunoTherapeutics (BTX) +23%.Big Rock Partners Acquisition (BRPA) +23%.T...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Clinical-stage biotechnology company Vaxart  (NASDAQ: VXRT ), as the name implies, is known for developing vaccines. There are other, more famous coronavirus vaccine makers out there, but VXRT stock is cheap and m...